Company Valuation: MedCap AB

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025 2026 2027 2028
Market Cap 1 4,997 8,899 8,278 7,517 - -
Change - 78.07% -6.99% -9.19% - -
Enterprise Value (EV) 1 4,997 9,176 8,359 7,724 7,444 7,130
Change - 83.61% -8.9% -7.59% -3.63% -4.22%
P/E 29.1x 42.9x - 29x 24.6x 22x
PBR - 6.95x - 4.35x 3.69x 3.16x
PEG - 2.1x - - 1.4x 1.9x
Capitalization / Revenue - 4.93x 3.93x 3.22x 2.97x 2.8x
EV / Revenue - 5.08x 3.97x 3.3x 2.94x 2.65x
EV / EBITDA - 23.7x 18.3x 14.6x 12.6x 11.2x
EV / EBIT - 33.7x 27.6x 21.8x 18.1x 15.6x
EV / FCF - 28.8x 26.4x 227x 22.3x 19.4x
FCF Yield - 3.47% 3.79% 0.44% 4.49% 5.16%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 11.6 14 - 17.25 20.37 22.71
Distribution rate - - - - - -
Net sales 1 - 1,807 2,108 2,338 2,531 2,687
EBITDA 1 - 387.7 456.3 530 590 638
EBIT 1 - 272.3 302.9 355 412 457
Net income 1 172.2 207.4 219.8 259 306 341
Net Debt 1 - 276.5 81.3 207 -73 -387
Reference price 2 337.50 601.00 549.00 500.50 500.50 500.50
Nbr of stocks (in thousands) 14,807 14,807 15,078 15,019 - -
Announcement Date 1/31/24 1/31/25 2/5/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- 3.3x14.57x - 780M
27.85x11.03x18.94x1.91% 33.99B
15.13x8.25x13.25x6.77% 21.9B
16.25x8.07x13.44x3.87% 16.14B
12.5x4.48x8.1x3.5% 3.38B
9.55x0.87x5.06x4.76% 1.15B
11.07x12.09x10.64x12.1% 962M
10.5x8.42x8.48x6.14% 801M
Average 14.69x 7.07x 11.56x 5.58% 9.89B
Weighted average by Cap. 20.59x 9.14x 15.33x 3.95%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA